VA Disability for IBS Secondary to PTSD: Brain-Gut Mechanism (2026)

Why IBS Is Recognized as Secondary to PTSD

Irritable bowel syndrome is the most common functional gastrointestinal disorder, affecting roughly 10–15 percent of the general population. In veterans with PTSD, prevalence is substantially higher — multiple studies have documented IBS rates two to three times that of the general veteran population. The relationship is not coincidence; the underlying neurobiology of PTSD directly produces the gut dysregulation that defines IBS.

The Department of Veterans Affairs has long recognized functional gastrointestinal disorders as legitimate consequences of psychiatric conditions, particularly trauma-related disorders. The current Rome IV diagnostic framework explicitly identifies IBS as a disorder of gut-brain interaction (DGBI), reflecting the consensus that brain-gut axis dysfunction is the underlying pathophysiology.

The Brain-Gut Axis Mechanism

The brain-gut axis is the bidirectional communication system linking the central nervous system to the enteric nervous system that controls gastrointestinal function. PTSD disrupts this axis at multiple levels.

Autonomic Nervous System Dysregulation

PTSD produces sustained sympathetic hyperactivity and reduced parasympathetic (vagal) tone. The vagus nerve is the primary parasympathetic input to the gut. Reduced vagal tone alters gastric and colonic motility, slows transit in some patients, accelerates it in others, and disrupts the normal coordination of intestinal contractions.

HPA Axis and Stress Hormones

Chronic activation of the hypothalamic-pituitary-adrenal axis produces sustained elevations of cortisol and corticotropin-releasing hormone (CRH). CRH directly affects intestinal motility and visceral sensitivity. Cortisol affects intestinal permeability and the gut immune system.

Visceral Hypersensitivity

PTSD-induced changes in central pain processing — particularly in the limbic system and anterior cingulate cortex — produce increased visceral sensitivity. Normal gastrointestinal sensations (gas, distension, peristalsis) are perceived as painful or distressing. This is the neurobiological basis for the abdominal pain that defines IBS.

Altered Gut Microbiome

The clinical literature increasingly recognizes that chronic stress alters the gut microbiome composition. Microbiome shifts in turn affect the production of short-chain fatty acids, neurotransmitter precursors (the gut produces approximately 90 percent of the body's serotonin), and inflammatory mediators that further perturb gut function.

Sleep Disruption Mediating Effect

PTSD-related sleep disturbance independently disrupts gastrointestinal regulation. Sleep deprivation alters gut motility, immune function, and visceral sensitivity, compounding the direct PTSD effects.

Diagnosing IBS Under Rome IV Criteria

The current standard for IBS diagnosis is the Rome IV criteria (2016, with continued use in 2026 practice). The diagnosis is clinical and does not require imaging or invasive testing in patients without alarm features.

Rome IV Criteria

Recurrent abdominal pain on average at least one day per week in the last three months, associated with two or more of the following: related to defecation, associated with a change in frequency of stool, or associated with a change in form (appearance) of stool. Symptoms must have been present for at least the past three months with onset at least six months before diagnosis.

Exclusion of Organic Disease

Routine screening typically includes complete blood count, comprehensive metabolic panel, celiac serologies, and (when alarm features are present) colonoscopy or imaging. The diagnosis of IBS is made after organic causes such as inflammatory bowel disease, colorectal cancer, celiac disease, and microscopic colitis have been excluded.

Alarm Features

Onset after age 50, gastrointestinal bleeding, unintentional weight loss, family history of colon cancer or IBD, nocturnal symptoms, or progressive worsening warrant additional workup. In their absence, IBS can be diagnosed clinically without extensive testing.

Rating Under DC 7319

IBS is rated under 38 CFR 4.114, Diagnostic Code 7319 (irritable colon syndrome).

30 Percent

Severe; diarrhea, or alternating diarrhea and constipation, with more or less constant abdominal distress.

10 Percent

Moderate; frequent episodes of bowel disturbance with abdominal distress.

0 Percent

Mild; disturbances of bowel function with occasional episodes of abdominal distress.

The descriptors are subjective, and detailed documentation of symptom frequency, severity, and functional impact is essential. A symptom diary tracking pain, bowel pattern, and impact on daily activities supports the rating analysis.

IBS Subtypes

Rome IV recognizes four IBS subtypes based on the predominant stool pattern. Each subtype has implications for the rating analysis under DC 7319.

IBS-D (Diarrhea-Predominant)

Loose or watery stools more than 25 percent of the time, hard or lumpy stools less than 25 percent of the time. Often associated with urgency and impaired ability to leave home or workplace.

IBS-C (Constipation-Predominant)

Hard or lumpy stools more than 25 percent of the time, loose or watery stools less than 25 percent of the time. Often associated with straining, sense of incomplete evacuation, and abdominal distention.

IBS-M (Mixed)

Both hard or lumpy stools and loose or watery stools more than 25 percent of the time. The DC 7319 criteria specifically reference "alternating diarrhea and constipation," making IBS-M a fit for the 30 percent criteria when severity is met.

IBS-U (Unclassified)

Patients meeting IBS criteria whose bowel pattern does not fit one of the above categories.

Medication-Mediated Contribution

Some PTSD medications affect gastrointestinal function and can contribute to or worsen IBS-type symptoms. SSRIs and SNRIs frequently produce GI side effects including diarrhea, nausea, and abdominal pain. Tricyclic antidepressants tend to produce constipation. The contribution of medication should be considered in the nexus analysis, and a thorough opinion can address both the direct PTSD-mediated mechanism and any medication-mediated contribution.

Evidence Required for the Claim

A defensible IBS-secondary-to-PTSD claim typically rests on the following evidence.

Existing PTSD Service Connection

The PTSD service connection must be established. The PTSD rating decision provides the foundation.

IBS Diagnosis

Diagnosis by a primary care physician or gastroenterologist, supported by Rome IV criteria documentation. Records should include the work-up performed to exclude organic disease.

Symptom Documentation

Records describing symptom frequency, severity, and pattern over time. A patient symptom diary or bowel diary is particularly useful for the rating analysis.

Treatment History

Records of dietary interventions (low-FODMAP, fiber adjustments), pharmacotherapy (antispasmodics, antidiarrheals, laxatives, neuromodulators such as TCAs at IBS doses), and treatment response.

Lay Statements

Statements from the veteran, spouse, or others describing the impact of IBS symptoms on daily activities, social functioning, occupational performance, and the temporal relationship to PTSD symptoms.

Medical Nexus Opinion

A licensed physician's opinion articulating the brain-gut axis mechanism connecting PTSD to IBS, using the "at least as likely as not" standard, and citing the relevant clinical literature.

Building the Nexus Letter

A defensible nexus letter for IBS secondary to PTSD contains the following elements.

Identification of the Service-Connected PTSD

The letter should reference the existing PTSD service connection, current rating, and current treatment regimen.

Current IBS Diagnosis

The letter should identify the IBS diagnosis with reference to Rome IV criteria, the work-up performed to exclude organic disease, the IBS subtype (IBS-D, IBS-C, IBS-M, IBS-U), and the predominant symptoms.

Brain-Gut Axis Mechanism

The opinion should articulate the multiple pathways — autonomic dysregulation, HPA axis activation, visceral hypersensitivity, microbiome alterations, sleep-mediated effects — by which PTSD causes or aggravates IBS, supported by reference to the clinical literature on disorders of gut-brain interaction.

Causation or Aggravation Specification

Whether PTSD caused new-onset IBS or aggravated a pre-existing condition. For aggravation, the baseline and increment should be characterized.

Medication Contribution (If Applicable)

Where PTSD medications contribute to IBS symptoms, the letter may address both pathways — the direct PTSD-mediated mechanism and the medication-mediated mechanism.

"At Least as Likely as Not" Language

The opinion must use the VA's required threshold.

Records-Based Review

The letter should affirm that the physician reviewed the PTSD records, GI evaluation, treatment history, and any symptom diary before forming the opinion.